13 August 2020PatentsRory O'Neill

USPTO urges Fed Circuit to wait for SCOTUS on Arthrex

The US Patent and Trademark Office (USPTO) wants a federal appeals court to hold off on a dispute over Patent Trial and Appeal Board (PTAB) fees until the US Supreme Court has resolved Arthrex.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Patents

USPTO reveals post-Arthrex review process

30 June 2021 As a result of the recent Supreme Court decision in US v Arthrex, the US Patent and Trademark Office issued new interim procedures on Tuesday, June 29, that give the office’s director the authority to rehear final Patent Trial and Appeal Board rulings.

Patents

Brown Rudnick hires Greenberg Gross partner

20 August 2020 Brown Rudnick has strengthened its Orange County office with the addition of David Stein as a partner in the firm’s IP and commercial litigation practice group.

Patents

USPTO wants SCOTUS to halt Arthrex appeals

29 July 2020 The USPTO wants the country’s Supreme Court to delay dealing with a combined petition challenging almost 40 court judgments until a constitutional snag has been resolved.

Lululemon counsel on why Nike's 'Flyknit' claim construction faltered

Team of 12 move from Morris Manning to Bradley

WIPR Diversity & Inclusion reveals Top 100 People in IP for 2025

Lenovo’s legal leader: We should be ‘enablers, not blockers’

Polsinelli steps up trade practice with hire of former ITC general counsel

Resilience and the power of brands: Elisabeth Stewart Bradley on 9/11, inclusion and the INTA presidency

Sterlington expands patent litigation team with new hire

‘Now is the time to scale rapidly’: Microsoft supports AI patent tool

USPTO urges Fed Circuit to wait for SCOTUS on Arthrex

More on this story

Editor's picks

Editor's picks

More articles